glp 1 r retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide | GLP-1R/GIPR/GCGR ligand |
Description
According to the company's own website disclosures, Trinity Meds patients typically experience 1 to 2 pounds per week of weight loss after 4 weeks, involving healthy diet and exercise changes - but the company also notes that results vary, fat loss figures shown on the site are not typical, and outcomes depend on starting weight and program adherence
Additionally, improved insulin sensitivity may affect renal sodium handling and fluid balance
Cardoso, P
Biological pathways affected by GLP-1 medicines How GLP-1 medicines confer benefits partially independent of weight loss remains incompletely understood
The positive results were observed alongside weight loss and independently of it
